Potassium and Apremilast drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium (potassium) and Apremilast (apremilast). Common drug interactions include diarrhoea among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium and Apremilast. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.

What is Apremilast?

Apremilast has active ingredients of apremilast. eHealthMe is studying from 4,162 Apremilast users. Check the latest studies of Apremilast.



On Jul, 15, 2026

17 people who take Potassium and Apremilast together, and have interactions are studied.

Potassium and Apremilast drug interactions.

What are the common drug interactions of Potassium and Apremilast, by gender? *:

female:

  1. Diarrhoea
  2. Affective disorder (mental disorder)
  3. Abdominal hernia
  4. Abdominal pain
  5. Chest discomfort
  6. Constipation
  7. Flatulence (flatus expelled through the anus)
  8. Gastric ulcer (stomach ulcer)
  9. Headache (pain in head)
  10. Loss of consciousness

male:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Dizziness
  4. Fatigue (feeling of tiredness)
  5. Haematochezia (passage of stools containing blood)
  6. Heart rate increased
  7. Hypotension (abnormally low blood pressure)
  8. Muscle fatigue (a condition in which muscles cannot exert their normal force)
  9. Muscular weakness (muscle weakness)
  10. Pain in extremity

What are the common drug interactions of Potassium and Apremilast, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chest discomfort
  2. Loss of consciousness
  3. Polycystic ovaries (cysts in the ovaries that occurs when the follicle stops developing)

50-59:

  1. Muscle spasms (muscle contraction)
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Hypotension (abnormally low blood pressure)
  5. Muscle fatigue (a condition in which muscles cannot exert their normal force)
  6. Therapeutic response decreased (less preventive response)

60+:

  1. Asthenia (weakness)
  2. Colon cancer
  3. Rash papular (redness with papule)
  4. Weight decreased
  5. Diarrhoea
  6. Flatulence (flatus expelled through the anus)
  7. Gastric ulcer (stomach ulcer)
  8. Haematochezia (passage of stools containing blood)
  9. Heart rate increased
  10. Muscular weakness (muscle weakness)

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 12 people, 70.59%
  2. High Blood Pressure: 6 people, 35.29%
  3. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 29.41%
  4. Pain: 4 people, 23.53%
  5. Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 3 people, 17.65%
  6. Iron Deficiency: 3 people, 17.65%
  7. Gastric Ulcer (stomach ulcer): 3 people, 17.65%
  8. Joint Pain: 2 people, 11.76%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 11.76%
  10. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and Apremilast?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium and Apremilast:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Apremilast:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Apremilast and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium and apremilast (the active ingredients of Potassium and Apremilast, respectively), and Potassium and Apremilast (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: